Guidelines for the likely 20 to 30% of pain patients who have a genetic defect
involving one of three major CYP450 enzymes and so cannot effectively metabolize certain
opioids that must be converted to a metabolite to be effective.…Read More
Vertical Health Media, LLC does not, by publication of the advertisements contained herein, express endorsement or verify the accuracy and effectiveness of the products and claims contained therein. Vertical Health Media, LLC disclaims any liability for damages resulting from the use of any product advertised herein and suggests that readers fully investigate the products and claims prior to purchasing. The views of the authors are not necessarily those of Vertical Health Media, LLC.
Practical Pain Management is sent without charge 10 times per year to pain management clinicians in the US.
Use of this website is conditional upon your acceptance of our user agreement.